SI-Bone, Inc. Data Breach Notification Letter — Free Case Review

SI-Bone, Inc. is a medical device company specializing in minimally invasive surgical solutions for the spine and pelvis, most notably for the treatment of sacroiliac joint disorders. In the course of designing, manufacturing, distributing, and supporting specialized orthopedic implants and surgical instrumentation, the company routinely collects, processes, and stores vast quantities of sensitive data. This includes proprietary clinical trial data, physician credentials, and detailed patient information associated with medical procedures, surgical planning, and healthcare billing. Because of its pivotal role in the medical supply and clinical ecosystem, SI-Bone maintains deep integrations with healthcare providers, hospitals, and surgical centers, making it a repository for highly sensitive personal and protected health information.

In 2025, SI-Bone, Inc. reported a significant cybersecurity incident to the Office of the Texas Attorney General. While the full forensic scope continues to be evaluated, breaches affecting medical device manufacturers and healthcare technology providers typically involve sophisticated cyberattacks, such as unauthorized intrusions into enterprise database environments, ransomware deployments, or the exploitation of vulnerable third-party vendor platforms. In many instances, threat actors target these networks specifically to harvest valuable corporate assets, intellectual property, and deeply personal medical or employee records that command a high value on the dark web.

The data compromised in incidents of this nature routinely includes a combination of personally identifiable information (PII) and protected health information (PHI), such as full legal names, dates of birth, Social Security numbers, medical record numbers, surgical and diagnostic details, health insurance information, and financial data. The exposure of this information creates severe, long-term risks for affected individuals. Unlike a stolen credit card, which can be easily cancelled and replaced, compromised medical and biometric-adjacent data cannot be altered. Victims face a heightened and persistent danger of medical identity theft—where unauthorized actors utilize stolen details to obtain medical care, prescription drugs, or bill insurance providers—as well as conventional financial fraud, tax refund schemes, and targeted phishing attacks.

As an entity handling sensitive medical and consumer data, SI-Bone, Inc. was bound by stringent legal obligations to secure its network infrastructure and safeguard consumer privacy. Under federal regulations such as the Health Insurance Portability and Accountability Act (HIPAA), as well as state-level data protection statutes including the Texas Identity Theft Enforcement and Protection Act, organizations holding sensitive health and personal records are legally mandated to implement robust administrative, physical, and technical safeguards. These include mandatory data encryption, multi-factor authentication, regular vulnerability assessments, and strict access controls. The occurrence of a data breach of this scale strongly suggests potential systemic failures in maintaining adequate cybersecurity measures, leaving the company vulnerable to preventable intrusions.

Receiving a data breach notification letter from SI-Bone, Inc. serves as formal legal acknowledgment that your confidential information was compromised due to corporate security negligence. Under modern class action jurisprudence, the receipt of such a notice establishes legal standing to pursue claims against the responsible entity, even before explicit financial loss materializes. Our class action law firm is actively investigating potential legal claims on behalf of affected individuals. We handle these cases on a contingency fee basis, meaning you pay absolutely nothing out of pocket, and our firm only collects a fee if a financial recovery is successfully obtained on your behalf.